A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5610 participants.
Also called NCT07567001
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 5,610 participants
- Sponsor
- Registry
-
NCT07567001
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, Denmark, France, Germany, Greece, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, South Africa, South Korea, Spain, Taiwan, Türkiye, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT07567001. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-11 (actual); primary completion 2029-07-23 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Acronym
- HF-POLARIS
- Condition
- Obesity
- Condition
- Heart Failure
- Intervention (Drug)
- NNC0487-0111
- Intervention (Drug)
- Placebo
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct07567001- Content hash
e0244117776379c45040d538fd96b66cbee5eddc0acda40f3a4639862b7477ef